Decoding circulating tumor dna to identify durable benefit from immunotherapy in lung cancer

HIGHLIGHTS

  • who: Hylke C. Donker from the Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, the Netherlands have published the research work: Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer, in the Journal: (JOURNAL)
  • what: While the model as a predictor is not perfect, the inherent inspectable nature of the model can be used to help guide the interpretation of the mutation dynamics on treatment outcome (Fig S3, Supplementary Material, illustrating the two best and two worst preu00ad dictions). Relative to a non-informative random classifier (area . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?